Bajaj Healthcare Limited (BHL), a leading specialized chemical and pharmaceutical manufacturer, has announced the re-appointment of Mr. Anil Champalal Jain as its Managing Director. The new term is set to begin on April 1, 2026. A veteran of the pharmaceutical industry, Mr. Jain has been a driving force behind the company’s expansion into Active Pharmaceutical Ingredients (APIs) and finished formulations. This move ensures leadership continuity as the company seeks to scale its manufacturing capabilities and global export footprint over the coming years.
Trending
- Pernod Ricard India Appoints Sonia Arora as Director of Consumer Insights
- PM Narendra Modi Becomes India’s Longest-Serving Head of Government
- Whole-time Director Indirakumar Resigns from Indrayani Biotech Board
- Secretary Debashree Mukherjee Assigned Additional Charge as Chairperson, NCVET
- Chief Growth Officer Amber Faulkner Joins Droga5 London
- Minister Laljit Singh Bhullar Resigns from Punjab Cabinet Following Official’s Suicide
- Sagarsoft (India) Appoints Finance Veteran Kanakadhara Srinivasan to its Board
- IAS Pramod Kumar Meherda Assigned Additional Charge as CEO, NRAA
